Chinoy et al. Baricitinib in IIM. Delayed-start clinical trial. 15 patients. 14/15 improved at 24 weeks (the other withdrew). 50% vs 100% at week 12 (delayed start group initiation). Stats confuse me a bit here but promising. @RheumNow #ACR24 Abstr#1731 https://t.co/orewsxbPpL https://t.co/5AyRpYJdec
Links:
Baricitinib in the Treatment of Adult Idiopathic Inflammatory Myopathy: A Rando…
https://acrabstracts.org/abstract/baricitinib-in-the-treatment-of-adult-idiopat…
17-11-2024